The Latest Breaking News on Pharma

Friday Plans has a stellar 4.3-star rating on Trustpilot, with 40,000+ subscribers praising the convenience, speed, affordability, and effectiveness of their Viagra and Cialis products.

Third of voters reject Pascal Soriot’s deal but some say it is deserved as he had been ‘massively underpaid’

The pharma industry’s resilience and long-term prospects are driven by rising healthcare demand, an enhanced focus on precision medicines, and technological advancements. Hence, let’s take a look at pharma stocks Perrigo Company (PRGO), Amneal Pharmaceuticals (AMRX), and Supernus Pharmaceuticals (SUPN), which could diversify your investments. Read on….

The Pharma sector’s innovative trial methodologies and shift toward customized medicine signal transformative growth potential in the pharmaceutical industry. While leading Pharma stocks Canopy Growth (CGC) and Novo Nordisk (NVO) stand to benefit, let us analyze which of them is a better investment.

The pharmaceutical industry is poised for robust growth owing to technological advancements and growing healthcare needs. Given this backdrop, let’s analyze Aurora Cannabis (ACB) and Merck & Co. (MRK) to determine which of the two stocks holds greater potential for investors. Read on….

Exclusive: Multi-dose vials could push up charge per patient, with experts warning cost could widen inequalities

Cost of antibiotics and painkillers have registered a marginal hike in cost starting with the drug price regulator National Pharmaceutical Pricing Authority’s latest notification

From yesterday's decision by Judge Gregory Woods (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt: Cassava Sciences, Inc. ("Cassava") is a biotechnology company that is conducting clinical trials for an Alzheimer's drug called simufilam. Following the second phase of the simufilam clinical trials, multiple short sellers, most of them scientists, published…

Exclusive: Millions more GP appointments potentially created as a result of closures